Panion & Bf Biotech Inc.

Taiwan Stock Exchange 1760.TW

Panion & Bf Biotech Inc. Debt to Equity Ratio for the year ending December 31, 2023: 0.38

Panion & Bf Biotech Inc. Debt to Equity Ratio is 0.38 for the year ending December 31, 2023, a 58.48% change year over year. Debt to equity ratio represents the financing from debt versus equity. Higher ratio indicates more debt reliance, suggesting potential risk.

Panion & Bf Biotech Inc. Debt to Equity Ratio for the year ending December 31, 2022 was 0.24, a -7.57% change year over year.
Panion & Bf Biotech Inc. Debt to Equity Ratio for the year ending December 31, 2021 was 0.26, a -73.99% change year over year.
Panion & Bf Biotech Inc. Debt to Equity Ratio for the year ending December 31, 2020 was 1.00, a 1,124.06% change year over year.
Panion & Bf Biotech Inc. Debt to Equity Ratio for the year ending December 31, 2019 was 0.08, a 0.00% change year over year.

Key data

Date	Debt to Equity Ratio	Debt to Income Ratio	Debt to Tangible Net Worth Ratio	Dividend Coverage Ratio

Taiwan Stock Exchange: 1760.TW

Panion & Bf Biotech Inc.

CEO	Mr. Tsung-Ming Chiang
IPO Date	Dec. 20, 2007
Location	Taiwan
Headquarters	Building F
Employees	321
Sector	Consumers Staples
Industries Personal Care Biotechnology Cleaning Supplies Cosmetics Dental Care Drugstores & Retail Pharmacies Pet Food Pharmaceuticals

Description

Panion & Bf Biotech Inc., a biotechnology pharmaceutical company, manufactures and sells various pharmaceutical products in Taiwan. The company offers products in the areas of medical beauty, kidney, respiratory tract, gastrointestinal tract, and body and hair cleaning. It also provides oral drugs and topical preparations; hand and mechanical disinfection, body lotion, and skin disinfection products; and pet health products, including surgical and skin prescriptions. Panion & Bf Biotech Inc. was founded in 1976 and is headquartered in Taipei, Taiwan.

Key trends

Past 5 years